text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 75695-93-1 | Product Number: I0876


Purity: >98.0%(HPLC)
  • Isopropyl Methyl 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
  • 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Isopropyl Methyl Ester
  • 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Isopropyl Methyl Ester
  • Isopropyl Methyl 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
1   6  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).

Product Number I0876
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__1__9H__2__1N__3O__5 = 371.39  
Physical State (20 deg.C) Solid
Storage Temperature -20°C
Condition to Avoid Heat Sensitive
CAS RN 75695-93-1
Reaxys Registry Number 6576633
PubChem Substance ID 253659791
Merck Index (14) 5240
MDL Number


Appearance Light orange to Yellow to Green powder to crystal
Purity(HPLC) min. 98.0 area%
Elemental analysis(Nitrogen) 10.70 to 11.60 %
Melting point 167.0 to 171.0 °C
Properties (reference)
Melting Point 169 °C
Hazard Statements H413 : May cause long lasting harmful effects to aquatic life.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P273 : Avoid release to the environment.
Related Laws: / Compliance with laws, Regulations
Transport Information:
HS Number 2934999090
Calcium Antagonist Isradipine

Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in

A. Kuzmin, E. Zvartau, G. L. Gessa, M. C. Martellotta, W. Fratta, Pharmacol. Biochem. Behav. 1992, 41, 497.

Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human α1C subunit

R. D. Zühlke, A. Bouron, N. M. Soldatov, H. Reuter, FEBS Lett. 1998, 427, 220.

Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats

B. I. Levy, M. Duriez, M. Phillipe, P. Poitevin, J. B. Michel, Circulation 1994, 90, 3024.


M. Schachter, J. Clin. Pharm. Ther. 1991, 16, 79.

Isradipine - another calcium-channel blocker for the treatment of hypertension and angina

L. M. Lopez, T. M. Santiago, Ann. Pharmacother. 1992, 26, 789.

PubMed Literature

Safety Data Sheet (SDS) Search
Please select Language.

The requested SDS is not available.

• Please check that the Product Number you have entered is correct.

• If your information is correct and you are still not able to view the requested SDS,  please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Other Documents